Osong Public Health Res Perspect.  2022 Oct;13(5):316-327. 10.24171/j.phrp.2022.0104.

India’s efforts to achieve 1.5 billion COVID-19 vaccinations: a narrative review

Affiliations
  • 1Asia Pacific Vaccine Access Facility, Asian Development Bank, New Delhi, India
  • 2School of Pharmaceutical and Populations Health Informatics, DIT University, Uttarakhand, India
  • 3Global Development Network, New Delhi, India

Abstract

The initial case of coronavirus disease 2019 (COVID-19) in India was reported on January 30, 2020, and subsequently, the number of COVID-19-infected patients surged during the first wave of April 2020 and the second wave in the same month of 2021. The government of India imposed a strict nationwide lockdown in April 2020 and extended it until May 2020. The second wave of COVID-19 in India overwhelmed the country’s health facilities and exhausted its medical and paramedical workforce. This narrative review was conducted with the aim of summarizing the evidence drawn from policy documents of governmental and nongovernmental organizations, as well as capturing India’s COVID-19 vaccination efforts. The findings from this review cover the Indian government’s vaccination initiatives, which ranged from steps taken to combat vaccine hesitancy to vaccination roadmaps, deployment plans, the use of digital health technology, vaccination monitoring, adverse effects, and innovative strategies such as Har Ghar Dastak and Jan Bhagidari Andolan (people’s participation). These efforts collectively culminated in the successful administration of more than 1.8 billion doses of COVID-19 vaccines in India. This review also provides insights into other countries’ responses to COVID-19 and guidance for future pandemics

Keyword

COVID-19; COVID-19 vaccines; Co-WIN; Vaccination hesitancy
Full Text Links
  • OPHRP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr